Gerresheimer AG (GRRMF)
OTC PINK OTC PINK Primary 
Gerresheimer cuts guidance for 2025 citing weak demand
German packaging and medical equipment maker Gerresheimer cut its guidance for 2025 on Monday, citing continued weak demand in the cosmetics sector and a decline in demand for containment solutions for liquid medications.
Gerresheimer: Strong Growth Projections Make Stock Look Cheap
Gerresheimer's strategic shift to value-driven solutions in pharma packaging supports higher margins and justifies a premium valuation over traditional packaging peers. Despite a weak Q1 with net loss and negative cash flow, management guides for strong revenue and margin recovery, projecting 22% EBITDA margin for FY 2025. Long-term outlook is robust: Management expects 8-10% annual revenue growth, EBITDA margin expansion, and double-digit EPS growth as Bormioli integration delivers synergies.
Gerresheimer AG (GRRMF) Q1 2025 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMF) Q1 2025 Earnings Conference Call April 11, 2025 4:00 AM ET Company Participants Guido Pickert - Vice President, Corporate Investor Relations Dietmar Siemssen - Chief Executive Officer Bernd Metzner - Chief Financial Officer Conference Call Participants James Vane-Tempest - Jefferies Victoria Lambert - Berenberg David Adlington - JPMorgan Odysseas Manesiotis - BNP Paribas Olivier Calvet - UBS Edward Hall - Stifel Delphine Le Louet - Bernstein Alexander Galitsa - HAIB Operator Ladies and gentlemen, welcome to the publication Q1 2025 Results Conference Call. I am George, the Chorus Call operator.
Gerresheimer's first-quarter results hit by low demand in moulded glass
German packaging and medical equipment maker Gerresheimer reported a lower organic core profit for the first quarter on Friday, hit by continued lower demand in moulded glass and shift in syringe revenues into later quarters.
Gerresheimer AG (GRRMF) Q4 2024 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMF) Q4 2024 Results Conference Call February 26, 2025 4:00 AM ET Company Participants Guido Pickert - Investor Relations Dietmar Siemssen - Chief Executive Officer Bernd Metzner - Chief Financial Officer & Member of the Management Board Conference Call Participants Oliver Reinberg - Kepler Cheuvreux Paul Knight - KeyBanc Oliver Metzger - ODDO James Vane-Tempest - Jefferies Victoria Lambert - Berenberg Falko Friedrichs - Deutsche Bank Olivier Calvet - UBS David Adlington - JPMorgan Edward Hall - Stifel Delphine Le Louet - Bernstein Alexander Galitsa - Hauck Aufhauser Investment Banking Operator Ladies and gentlemen, welcome to the publication of Q4 and Full Year 2024 Results Conference Call. I'm Vicki, the Chorus Call operator.
Gerresheimer slashes revenue guidance for 2025 in half
German packaging and medical equipment maker Gerresheimer halved its guidance for 2025 on Wednesday.
Gerresheimer draws interest from Phillips-Medisize and Bain, Bloomberg News reports
German medical packaging maker Gerresheimer has garnered interest from US medical solutions company Phillips-Medisize and buyout firm Bain Capital for parts or all of Gerresheimer, Bloomberg News reported on Wednesday, citing sources.
German packaging firm Gerresheimer exploring sale, Bloomberg News reports
German medical packaging maker Gerresheimer is exploring a potential sale amid interest from private equity funds, Bloomberg News reported on Friday, citing people familiar with the matter.
Gerresheimer shares jump as activist investor buys over 5% stake
Gerresheimer's shares rose as much as 6.8% on Wednesday after a regulatory filing showed activist investor Ricky Chad Sandler had bought a 5.43% stake in German medical packaging maker.
Gerresheimer AG (GRRMF) Q2 2024 Earnings Call Transcript
Gerresheimer AG (OTCPK:GRRMF) Q2 2024 Earnings Conference Call July 11, 2024 4:00 AM ET Company Participants Guido Pickert - IR Dietmar Siemssen - CEO Bernd Metzner - CFO Conference Call Participants Oliver Reinberg - Kepler Cheuvreux Victoria Lambert - Berenberg Oliver Metzger - ODDO Paul Knight - KeyBanc Annapurna Bain - Barclays Olivier Calvet - UBS Klaus Brune - Platow Verlag David Adlington - JPMorgan Edward Hall - Stifel Falko Friedrichs - Deutsche Bank Curtis Moiles - BNP Paribas Alexander Galitsa - Hauck Aufhauser Investment Banking Operator Ladies and gentlemen, welcome to the Gerresheimer AG's Q2 and First Half 2024 Results Conference Call. I am Charley, the Chorus Call operator.
Gerresheimer core profit meets forecast on weight-loss drug deals pipeline
Germany's Gerresheimer posted second-quarter adjusted core profit in line with market expectations on Thursday, driven by the deal pipeline for its plastics and devices segment, which supplies makers of weight-loss drugs with autoinjector pens.
